Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (341-350 of 682) with videos related to

Pageof 69
Sort By:
BMC Cancer|May 28, 2010
Expression signatures of TP53 mutations in serous ovarian cancersMarcus Q Bernardini, Tsukasa Baba, Paula S Lee, et al.
Gynecologic Oncology|April 17, 2013
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancerMicael Lopez-Acevedo, Laura J Havrilesky, Gloria Broadwater, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|August 11, 2007
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, Victoria Bae-Jump, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
SSM. Mental Health|July 29, 2025
Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare dataFariha Rahman, Oyomoare L Osazuwa-Peters, Clare Meernik, et al.
Cancers|April 13, 2024
Racial Differences in Vaginal Fluid Metabolites and Association with Systemic Inflammation Markers among Ovarian Cancer Patients: A Pilot StudyOyomoare L Osazuwa-Peters, April Deveaux, Michael J Muehlbauer, et al.
Cancer Research|October 18, 2000
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancerS Suzuki, D H Moore, D G Ginzinger, et al.
Scientific Reports|May 18, 2025
Lexical associations can characterize clinical documentation trends related to palliative care and metastatic cancerHao Yuan Yang, Karthik Raghunathan, Eric Widera, et al.
Pageof 69

Showing results (341-350 of 682) with videos related to

Sort By:
Pageof 69
BMC Cancer|May 28, 2010
Expression signatures of TP53 mutations in serous ovarian cancersMarcus Q Bernardini, Tsukasa Baba, Paula S Lee, et al.
Gynecologic Oncology|April 17, 2013
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancerMicael Lopez-Acevedo, Laura J Havrilesky, Gloria Broadwater, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|August 11, 2007
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, Victoria Bae-Jump, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
SSM. Mental Health|July 29, 2025
Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare dataFariha Rahman, Oyomoare L Osazuwa-Peters, Clare Meernik, et al.
Cancers|April 13, 2024
Racial Differences in Vaginal Fluid Metabolites and Association with Systemic Inflammation Markers among Ovarian Cancer Patients: A Pilot StudyOyomoare L Osazuwa-Peters, April Deveaux, Michael J Muehlbauer, et al.
Cancer Research|October 18, 2000
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancerS Suzuki, D H Moore, D G Ginzinger, et al.
Scientific Reports|May 18, 2025
Lexical associations can characterize clinical documentation trends related to palliative care and metastatic cancerHao Yuan Yang, Karthik Raghunathan, Eric Widera, et al.
Pageof 69